Overview A Confirmatory Study of Hepabulin IV in HBsAg Positive Liver Transplantation Recipients Status: Completed Trial end date: 2014-03-01 Target enrollment: Participant gender: Summary The purpose of this study is to Evaluate the efficacy and safety of Hepabulin IV (HBIG, a study drug) after liver transplantation. Phase: Phase 3 Details Lead Sponsor: SK Chemicals Co., Ltd.SK Chemicals Co.,Ltd.